Human fungal infection (Dermatophytosis/Mycosis) on the forearm. Photo by Asurnipal via Wikimedia Commons Nearly half of people living with HIV continue to experience skin conditions, despite major advances in antiretroviral therapy, according to new research led by investigators at George Washington University. The study, published through the DC Cohort—a major longitudinal project tracking HIV outcomes in the Washington, D.C. area—reviewed medical records from 11,738 adults

Stefania Nicoli, PhD. Photo courtesy Yale School of Medicine The outer surface of the skin, noted for its regenerative processes, may owe its resilience to lessons learned before birth. In a study published October 10 in Nature Communications , researchers at Yale School of Medicine report that embryonic skin stem cells establish the physical and molecular groundwork that allows the body to repair itself throughout life. Led by Kaelyn Sumigray, PhD, and Stefania Nicoli, PhD,

This image shows colonies of methicillin-resistant Staphylococcus aureus bacteria. Photo credit: Janice Haney Carr, Jeff Hageman, M.H.S, U.S. Centers for Disease Control and Prevention Researchers at the University of California San Diego School of Medicine have discovered a previously unrecognized mechanism by which Staphylococcus aureus delays wound healing. In a study, published in The   Journal of Clinical Investigation , the researchers found that quorum sensing—a proces

Photo by Photo by Judit Peter via Pexels Derm.city is pleased to announce the 4th annual short essay competition on the topic of...

Early research findings suggest that treatment with umbilical cord-derived mesenchymal stem cell conditioned medium (MSC-CM) may be...

A team of researchers from the University of Pennsylvania and Cincinnati Children’s Hospital Medical Center has developed an experimental...

Photo by: Judyta Dulnik via Wikimedia Commons Scientists have identified eight different types of fibroblasts and how they form “tissue...

Dr. Jean Tang. Photo courtesy Stanford Medicine News A phase 3 trial has demonstrated that a novel autologous gene-corrected cell...